Brett Sandercock - Aug 15, 2024 Form 4 Insider Report for RESMED INC (RMD)

Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Aug 15, 2024
Transactions value $
$0
Form type
4
Date filed
8/16/2024, 10:21 AM
Previous filing
Aug 12, 2024
Next filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +7.92K +8.89% $0.00 97K Aug 15, 2024 Direct F1
transaction RMD ResMed Common Stock Award $0 +841 +0.87% $0.00 97.8K Aug 15, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock unitsvest1/3each year on the anniversary of the grant.
F2 Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthegrant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.